Clinipace Worldwide Inc-医療機器分野:企業M&A・提携分析

◆英語タイトル:Clinipace Worldwide Inc - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011327
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月22日
◆ページ数:29
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Clinipace Worldwide Inc (Clinipace) is a contract research company that offers drug and medical devices development services. The company’s services include biostatistics, clinical monitory, chemistry, manufacturing and control, data management, GCP training, global study feasibility, medical affairs and writing. It also provides pharmacokinetic and pharmacodynamic studies, site selection and management, project management and regulatory affairs services. Clinipace offers services in therapeutic areas including dermatology, infectious disease, pain, ophthalmology, rheumatology, oncology, vaccines, and other cell and tissue based therapies. The company operates in partnership with research centers for its clinical research activities. It offers its services to biotechnology, pharmaceutical and medical device companies. The company has operational presence in North America, Europe, Asia Pacific, Israel and the Middle East and Latin America. Clinipace is headquartered in Morrisville, North Carolina, the US.

Clinipace Worldwide Inc – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Clinipace Worldwide Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Clinipace Worldwide Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Clinipace Worldwide Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Clinipace Worldwide Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Clinipace Worldwide Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Clinipace Worldwide Inc, Medical Equipment, Deal Details 10
Venture Financing 10
Clinipace Raises USD3 Million in Venture Financing 10
Clinipace Worldwide Raises USD50 Million in Venture Financing 11
Clinipace Raises USD4 Million in Venture Financing 12
Clinipace Raises US$3 Million In Venture Financing 13
Clinipace Worldwide Raises US$9 Million In Venture Financing 14
Clinipace Raises US$13 Million In Venture Financing 15
Clinipace Worldwide Secures US$15 Million In Series C Financing 16
Clinipace Worldwide Secures US$8 Million In Venture Financing Round 17
Acquisition 18
Clinipace Worldwide Acquires PFC Pharma Focus 18
Clinipace Worldwide Inc – Key Competitors 19
Clinipace Worldwide Inc – Key Employees 20
Clinipace Worldwide Inc – Locations And Subsidiaries 22
Head Office 22
Other Locations & Subsidiaries 22
Recent Developments 24
Corporate Communications 24
Oct 27, 2017: Clinipace Worldwide Executive Joins Board of Kidney Health Initiative 24
Oct 17, 2017: Clinipace Worldwide Co-founder & CEO Jeff Williams to Resign as CEO 25
Aug 31, 2017: Clinipace Worldwide Adds Industry Veteran Steve Skolsky to Board of Directors 26
Aug 07, 2017: Clinipace Worldwide Appoints Nikolas Burlew To Head Up New RSD Global Consulting Group 27
May 18, 2017: Clinipace Worldwide Hires Nephrologist Eric B. Grossman, MD, as Vice President and Medical Director 28
Appendix 29
Methodology 29
About GlobalData 29
Contact Us 29
Disclaimer 29

List of Tables
Clinipace Worldwide Inc, Medical Equipment, Key Facts 2
Clinipace Worldwide Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Clinipace Worldwide Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Clinipace Worldwide Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Clinipace Worldwide Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Clinipace Worldwide Inc, Deals By Market, 2011 to YTD 2017 8
Clinipace Worldwide Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Clinipace Raises USD3 Million in Venture Financing 10
Clinipace Worldwide Raises USD50 Million in Venture Financing 11
Clinipace Raises USD4 Million in Venture Financing 12
Clinipace Raises US$3 Million In Venture Financing 13
Clinipace Worldwide Raises US$9 Million In Venture Financing 14
Clinipace Raises US$13 Million In Venture Financing 15
Clinipace Worldwide Secures US$15 Million In Series C Financing 16
Clinipace Worldwide Secures US$8 Million In Venture Financing Round 17
Clinipace Worldwide Acquires PFC Pharma Focus 18
Clinipace Worldwide Inc, Key Competitors 19
Clinipace Worldwide Inc, Key Employees 20
Clinipace Worldwide Inc, Other Locations 22
Clinipace Worldwide Inc, Subsidiaries 23

★海外企業調査レポート[Clinipace Worldwide Inc-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Intersect ENT Inc (XENT):企業の財務・戦略的SWOT分析
    Summary Intersect ENT Inc (Intersect), formerly Sinexus Inc, is a medical technology company that offers chronic sinusitis solutions. The company offers steroid releasing implants and mini steroid implants. It provides surgical solutions for patients, disease recurrence with recurrent symptoms. Inte …
  • Minor International PCL:企業の戦略・SWOT・財務情報
    Minor International PCL - Strategy, SWOT and Corporate Finance Report Summary Minor International PCL - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Teledyne Technologies Inc (TDY):企業の財務・戦略的SWOT分析
    Teledyne Technologies Inc (TDY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • PFSweb Inc (PFSW):企業の財務・戦略的SWOT分析
    Summary PFSweb Inc (PFSweb) is an eCommerce solutions provider. Its various services include agency services, marketing services, technology and financial services. The company offers solutions for omnichannel operations, technology ecosystem, and strategic commerce consulting. Its technology ecosys …
  • Exxon Mobil Corp Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2017
    Exxon Mobil Corp Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2017 Summary Exxon Mobil Corp (ExxonMobil) is an integrated oil and gas company that explores for and produces crude oil and natural gas; manufactures petroleum products; transports and sells crude oil and petro …
  • Currence Holding B.V.
    Currence Holding B.V. - Strategy, SWOT and Corporate Finance Report Summary Currence Holding B.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Stanley Black & Decker Inc:戦略・SWOT・企業財務分析
    Stanley Black & Decker Inc - Strategy, SWOT and Corporate Finance Report Summary Stanley Black & Decker Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • The PNC Financial Services Group Inc:企業のM&A・事業提携・投資動向
    The PNC Financial Services Group Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's The PNC Financial Services Group Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports …
  • Schlumberger Ltd (SLB):企業の財務・戦略的SWOT分析
    Schlumberger Ltd (SLB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Theravance Biopharma Inc (TBPH):企業の財務・戦略的SWOT分析
    Theravance Biopharma Inc (TBPH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Cooper-Standard Holdings Inc.:企業の戦略・SWOT・財務情報
    Cooper-Standard Holdings Inc. - Strategy, SWOT and Corporate Finance Report Summary Cooper-Standard Holdings Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • DesignMedix Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary DesignMedix Inc (DesignMedix) is a biotechnology company that develop drugs to overcome drug resistance in multiple diseases such as malaria and diarrhea. The company develops malaria cure drugs, malaria preventive drugs and anti-bacterial drugs. It develops DM1157, a drug candidate that pro …
  • PolyNovo Biomaterials Pty Ltd:企業の製品パイプライン分析2018
    Summary PolyNovo Biomaterials Pty Ltd (PolyNovo), a subsidiary of PolyNovo Ltd is a medical technology company that develops, designs and manufactures controlled bioeroding tissue and orthopedic solutions. The company’s Novosorb polymers are based on polyurethanes, a polymer family used in medical a …
  • Mace Group Ltd:企業の戦略・SWOT・財務情報
    Mace Group Ltd - Strategy, SWOT and Corporate Finance Report Summary Mace Group Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Kazanorgsintez (KZOS):企業の財務・戦略的SWOT分析
    Kazanorgsintez (KZOS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Galapagos NV (GLPG):企業の財務・戦略的SWOT分析
    Summary Galapagos NV (Galapagos) is a biotechnology company that discovers and develops small molecule medicines. The company’s clinical pipeline include filgotinib, which is in Phase III clinical trials for the treatment of rheumatoid arthritis and Crohn’s disease, Phase 2 and 3 trials for ulcerati …
  • Wilton Resources Inc (WIL):石油・ガス:M&Aディール及び事業提携情報
    Summary Wilton Resources Inc (Wilton Resources) is an exploration and development company that develops oil and gas reserves. The company offers exploration of underdeveloped conventional and unconventional resources with prime focus on African continent. It operates in the process of acquiring oil …
  • UCB S.A.:企業のM&A・事業提携・投資動向
    UCB S.A. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's UCB S.A. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital …
  • BioNTech AG-製薬・医療分野:企業M&A・提携分析
    Summary BioNTech AG (BioNTech) is a biotech company that develops biomarker based diagnostics. The company’s products include RNXtract and mammatyper, and cell and gene therapies. It pipeline products include BioNTech mRNA pharmaceuticals, BioNTech cell and gene, and BioNTech protein therapeutics. B …
  • Avacta Group Plc (AVCT):企業の製品パイプライン分析2018
    Summary Avacta Group Plc (Avacta) is a developer therapeutic molecules used in a wide range of life sciences applications in research and diagnostics. The company offers products that include optim and sensipod. It also develops UCB celltech that is an analytical instrument. Avacta’s sensipod is an …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆